UPDATE : Monday, December 10, 2018
상단여백
Celltrion unveils clinical trial results for rituximab biosimilar in US by Lee Han-soo 2018-12-06 11:11
Samsung BioLogics, Saint-Gobain sign supply agreement by Lee Han-soo 2018-12-05 14:01
Chong Kun Dang launches world’s 1st 2nd-generation anemia biosimilar by Lee Han-soo 2018-12-04 11:18
‘Rules to be tougher on patent transfer due to ToolGen case’ by Nam Doo-hyun 2018-11-29 11:48
Celltrion wins FDA nod for rituximab biosimilar by Lee Han-soo 2018-11-29 10:50
라인
Samsung BioLogics files administrative suit to refute accounting fraud ruling by Nam Doo-hyun 2018-11-28 15:30
Pharmaceuticals, biotechs rise with KOSPI rebound by Nam Doo-hyun 2018-11-27 11:53
Celltrion’s Remsima tops global sale of ₩1 trillion by Lee Han-soo 2018-11-23 14:54
Operating income declines at top 10 biotechs on KOSDAQ by Nam Doo-hyun 2018-11-22 11:15
Celltrion CEO involved in alleged ‘gapjil’ scandal by Lee Han-soo 2018-11-21 16:02
라인
US data crucial for Korean biosimilars after success in Europe by Nam Doo-hyun 2018-11-21 15:29
FDA OKs sale of Celltrion's HIV biosimilar by Lee Han-soo 2018-11-21 12:57
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug by So Jae-hyeon 2018-11-20 15:00
Celltrion Healthcare presents research results on using biosimilars in Europe by Lee Han-soo 2018-11-19 16:57
Bridge Bio applies for idiopathic pulmonary fibrosis treatment in US by Lee Han-soo 2018-11-19 11:58
라인
Tego Science sales plunge in Q3 by Lee Han-soo 2018-11-16 14:54
NIBEC wins patent for novel peptide in US by Lee Han-soo 2018-11-16 14:40
Samsung BioLogics fiasco hardly affects biotech stocks by Nam Doo-hyun 2018-11-16 11:30
Medipost mark profit losses in Q3 by Lee Han-soo 2018-11-15 15:18
[News Focus] Biotechs to suffer shocks from Samsung BioLogics mess by So Jae-hyeon 2018-11-15 14:56
여백
여백
여백
Back to Top